Graham Abbott

The Dr. Bronners soap company announced it has contributed $1 million to the psilocybin therapy legalization campaign in Oregon.

Cannabis supply company Advanced Nutrients says a shipment worth $250,000 was stolen during transit from its Washington-based facility to a warehouse in Valencia, California.

COVID-19 is spreading through the U.S. prison system like wildfire and people who remain locked up on cannabis and nonviolent drug charges are being forced to face their mortality.

Ontario’s cannabis wholesaler has announced plans for new craft cannabis regulations and to allow on-site cannabis shops for licensed growers.

The Last Prisoner Project and 4Front Ventures have partnered to provide liquid disinfectant products such as hand sanitizer to help reduce the spread of coronavirus in prisons.

Amid the pandemic crisis, California’s cannabis distributors have begun sharing information about which cannabis firms are reliable for paying their bills and which are not.

Canopy Growth Corp. has announced a series of changes for the Canadian company, including shutting down all of its operations in Africa, moving to an asset-light model in Latin America, and exiting the U.S. hemp cultivation scene.

As the coronavirus crisis continues to upset cannabis events and networking opportunities, the industry’s largest trade show is partnering with the largest business-focused online cannabis network.

A former Amazon employee who was fired for using medical cannabis has won a federal court decision that will send the resulting lawsuit back to New Jersey’s Supreme Court, where he has a much stronger shot at winning the case.

High Times CEO Stormy Simon announced she is running for political office in her home state of Utah.

Australian researchers have uncovered evidence that a cannabis-based treatment could be effective against chronic insomnia.

Researchers have confirmed the effectiveness of a cannabis “tolerance break,” demonstrating that cannabis tolerance is linked to neurometabolic alterations in the brain’s reward circuitry.

Businesses that operate adjacent to the legal cannabis industry will be ineligible for the federal coronavirus loan assistance plan signed by President Trump last month.

The DEA has removed Epidiolex, the CBD-based epilepsy medication made by GW Pharmaceuticals, from the federal controlled substances list.

The first federal prisoner in the U.S. to die from the novel coronavirus was locked up on nonviolent drug charges.

Cannabis advocacy group Last Prisoner Project has launched a round-up change donation program for cannabis retailers that will aid the organization’s efforts to free all prisoners locked up on cannabis charges.

New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.

Business analysts at DataTrek Research suggest more states could legalize adult-use cannabis in the near future to help their economies recover from the coronavirus pandemic.

Washington cannabis regulators have updated their guidelines for medical and adult-use cannabis dispensaries in the state after the governor issued a statewide shelter-in-place order.

With an increasing number of Americans seeking shelter at home, adult-use cannabis sales appear to have plummeted after a short period of intense stockpiling.